Viral-Related Neutrophil Response and Condition Severity in People With ARDS

NCT00548795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2020-10-14

No results posted yet for this study

Summary

Acute respiratory distress syndrome (ARDS) is a severe lung condition that can result from a bacterial infection in the lungs. Viral infections may impair the body's immune system response to bacteria, which may lead to more serious lung injury. This study will evaluate the association between the immune response and ARDS severity in people who have ARDS plus a viral infection.

Conditions

  • Respiratory Distress Syndrome, Adult

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • National Jewish Health

    lead OTHER

Principal Investigators

  • Jerry A. Nick, MD · National Jewish Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2011-01-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548795 on ClinicalTrials.gov